Date Filed | Type | Description |
10/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/19/2016 |
4/A
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 868,902 shares
@ $0.41, valued at
$356.2k
|
|
08/04/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 937,500 shares
@ $0.38, valued at
$356.3k
Granted 300,000 options
@ $0.38, valued at
$114k
|
|
06/03/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 180,000 options
@ $0.4, valued at
$72k
|
|
01/26/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 42,000 shares
@ $0.5911, valued at
$24.8k
|
|
01/19/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 44,200 shares
@ $0.5656, valued at
$25k
|
|
01/12/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 39,400 shares
@ $0.6243, valued at
$24.6k
|
|
01/06/2016 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 62,000 shares
@ $0.806, valued at
$50k
|
|
12/08/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 65,400 shares
@ $0.7634, valued at
$49.9k
|
|
10/26/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 18,400 shares
@ $1.3587, valued at
$25k
|
|
10/19/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 18,600 shares
@ $1.344, valued at
$25k
|
|
10/13/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 19,000 shares
@ $1.3004, valued at
$24.7k
|
|
10/05/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 40,700 shares
@ $1.2267, valued at
$49.9k
|
|
09/01/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 7,569 shares
@ $1.2946, valued at
$9.8k
|
|
07/31/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Converted 8,905 shares
@ $1.51, valued at
$13.4k
Converted 12 convertible preferred
@ $1.51, valued at
$18.4 |
|
05/08/2015 |
4
| Teper Daniel Gedeon (CEO) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 250,000 options
@ $1.87, valued at
$467.5k
|
|
07/03/2014 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
06/25/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/12/2014 |
4
| Teper Daniel Gedeon (CEO and Chairman) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 60 convertible preferred
@ $0 Bought 8,824 warrants
@ $0 |
|
02/06/2014 |
4
| Teper Daniel Gedeon (CEO and Chairman) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 750,000 options
@ $2.38, valued at
$1.8M
|
|
08/27/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/27/2013 |
3
| Teper Daniel Gedeon (Chairman & CEO) has filed a Form 3 on IMMUNE PHARMACEUTICALS INC |